<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d296" origId="Clofazimine"><sentence id="DrugDDI.d296.s0" origId="s0" text="Preliminary data which suggest that dapsone may inhibit the anti-inflammatory activity of Lamprene have not been confirmed."><entity charOffset="36-43" id="DrugDDI.d296.s0.e0" origId="s0.p3" text="dapsone" type="drug"/><entity charOffset="90-98" id="DrugDDI.d296.s0.e1" origId="s0.p7" text="Lamprene" type="drug"/><pair e1="DrugDDI.d296.s0.e0" e2="DrugDDI.d296.s0.e1" id="DrugDDI.d296.s0.p0" interaction="true"/><negationtags>Preliminary data which suggest that dapsone may inhibit &lt;xcope&gt;the anti-inflammatory activity of Lamprene have &lt;cue&gt;not&lt;/cue&gt; been confirmed&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d296.s1" origId="s1" text="If leprosy-associated inflammatory reactions develop in patients being treated with dapsone and clofazimine, it is still advisable to continue treatment with both drugs."><entity charOffset="3-10" id="DrugDDI.d296.s1.e0" origId="s1.p12" text="leprosy" type="drug"/><entity charOffset="84-91" id="DrugDDI.d296.s1.e1" origId="s1.p17" text="dapsone" type="drug"/><entity charOffset="96-107" id="DrugDDI.d296.s1.e2" origId="s1.p19" text="clofazimine" type="drug"/><entity charOffset="163-168" id="DrugDDI.d296.s1.e3" origId="s1.p27" text="drugs" type="drug"/><pair e1="DrugDDI.d296.s1.e0" e2="DrugDDI.d296.s1.e1" id="DrugDDI.d296.s1.p0" interaction="false"/><pair e1="DrugDDI.d296.s1.e0" e2="DrugDDI.d296.s1.e2" id="DrugDDI.d296.s1.p1" interaction="false"/><pair e1="DrugDDI.d296.s1.e0" e2="DrugDDI.d296.s1.e3" id="DrugDDI.d296.s1.p2" interaction="false"/><pair e1="DrugDDI.d296.s1.e1" e2="DrugDDI.d296.s1.e2" id="DrugDDI.d296.s1.p3" interaction="false"/><pair e1="DrugDDI.d296.s1.e1" e2="DrugDDI.d296.s1.e3" id="DrugDDI.d296.s1.p4" interaction="false"/><pair e1="DrugDDI.d296.s1.e2" e2="DrugDDI.d296.s1.e3" id="DrugDDI.d296.s1.p5" interaction="false"/></sentence></document>